Weining Zhang
Vancouver, BC V5Z4H4, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Partial rescue of some features of Huntington Disease in the genetic absence of caspase-6 in YAC128 mice.
Journal: Neurobiology of disease
Published: September 16, 2014
Anti-semaphorin 4D immunotherapy ameliorates neuropathology and some cognitive impairment in the YAC128 mouse model of Huntington disease.
Journal: Neurobiology of disease
Published: June 11, 2014
Hip14l-deficient mice develop neuropathological and behavioural features of Huntington disease.
Journal: Human molecular genetics
Published: October 19, 2012
A fully humanized transgenic mouse model of Huntington disease.
Journal: Human molecular genetics
Published: September 25, 2012
NP03, a novel low-dose lithium formulation, is neuroprotective in the YAC128 mouse model of Huntington disease.
Journal: Neurobiology of disease
Published: April 13, 2012
Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice.
Journal: Human molecular genetics
Published: February 14, 2012
Low levels of human HIP14 are sufficient to rescue neuropathological, behavioural, and enzymatic defects due to loss of murine HIP14 in Hip14-/- mice.
Journal: PloS one
Published: February 01, 2012
Rescue from excitotoxicity and axonal degeneration accompanied by age-dependent behavioral and neuroanatomical alterations in caspase-6-deficient mice.
Journal: Human molecular genetics
Published: January 21, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026